by Madaline Spencer | Apr 16, 2025
Carla Nester, MD, Professor of Pediatrics-Nephrology at the University of Iowa, discusses the recent U.S. Food and Drug Administration (FDA) approval of iptacopan as the first and only treatment of adults with C3 glomerulopathy (C3G). C3G is a rare...
by Madaline Spencer | Apr 15, 2025
A recent study published in the American Journal of Ophthalmology observed clinical outcomes in patients with peripheral ulcerative keratitis (PUK). Peripheral Ulcerative Keratitis PUK is an inflammatory disease characterized by peripheral corneal thinning. It...
by Madaline Spencer | Apr 14, 2025
Paul Bolno, MD, President and Chief Executive Officer of Wave Life Sciences, discusses positive results from the FORWARD-53 clinical trial evaluating WVE-N531 in patients with Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping. DMD affects...
by Madaline Spencer | Apr 10, 2025
A new study by Clarke and colleagues published in the Journal of Clinical Endocrinology & Metabolism highlights the safety and efficacy of TransCOn PTH (palopegteriparatide) to treat adults with hypoparathyroidism. Hypoparathyroidism Hypoparathyroidism is a rare...
by Madaline Spencer | Apr 9, 2025
Richard J. Nowak, MD, Director of the Myasthenia Gravis Clinic at Yale University, discusses positive data from the MINT clinical trial evaluating Uplizna (inebilizumab-cdon) in adults with generalized myasthenia gravis (gMG). MG is a chronic autoimmune...
